MoonLake Immunotherapeutics (MLTX)

MLTX Statistics

Total Valuation

MLTX has a market cap or net worth of $3.37 billion. The enterprise value is $2.97 billion.

Market Cap	3.37B
Enterprise Value	2.97B

Important Dates

The next estimated earnings date is Wednesday, August 6, 2025, before market open.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	n/a

Share Statistics

MLTX has 63.47 million shares outstanding. The number of shares has increased by 14.55% in one year.

Current Share Class	63.47M
Shares Outstanding	63.47M
Shares Change (YoY)	+14.55%
Shares Change (QoQ)	+0.26%
Owned by Insiders (%)	10.95%
Owned by Institutions (%)	50.93%
Float	28.34M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	8.27
P/TBV Ratio	8.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 21.11, with a Debt / Equity ratio of 0.18.

Current Ratio	21.11
Quick Ratio	20.15
Debt / Equity	0.18
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-9,486.45

Financial Efficiency

Return on equity (ROE) is -30.64% and return on invested capital (ROIC) is -20.44%.

Return on Equity (ROE)	-30.64%
Return on Assets (ROA)	-19.85%
Return on Invested Capital (ROIC)	-20.44%
Return on Capital Employed (ROCE)	-35.04%
Revenue Per Employee	n/a
Profits Per Employee	-$1.45M
Employee Count	100
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, MLTX has paid $365,199 in taxes.

Income Tax	365,199
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +14.22% in the last 52 weeks. The beta is 1.27, so MLTX's price volatility has been higher than the market average.

Beta (5Y)	1.27
52-Week Price Change	+14.22%
50-Day Moving Average	44.31
200-Day Moving Average	45.37
Relative Strength Index (RSI)	67.35
Average Volume (20 Days)	468,268

Short Selling Information

The latest short interest is 6.07 million, so 9.57% of the outstanding shares have been sold short.

Short Interest	6.07M
Short Previous Month	6.12M
Short % of Shares Out	9.57%
Short % of Float	21.43%
Short Ratio (days to cover)	9.81

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-170.76M
Pretax Income	-58.02M
Net Income	-145.21M
EBITDA	-169.32M
EBIT	-170.76M
Earnings Per Share (EPS)	-$2.30

Balance Sheet

The company has $480.13 million in cash and $75.60 million in debt, giving a net cash position of $404.53 million or $6.37 per share.

Cash & Cash Equivalents	480.13M
Total Debt	75.60M
Net Cash	404.53M
Net Cash Per Share	$6.37
Equity (Book Value)	412.58M
Book Value Per Share	6.42
Working Capital	482.28M

Cash Flow

In the last 12 months, operating cash flow was -$139.78 million and capital expenditures -$342,520, giving a free cash flow of -$140.12 million.

Operating Cash Flow	-139.78M
Capital Expenditures	-342,520
Free Cash Flow	-140.12M
FCF Per Share	-$2.21

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MLTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.55%
Shareholder Yield	-14.55%
Earnings Yield	-4.31%
FCF Yield	-4.16%

Analyst Forecast

The average price target for MLTX is $73.33, which is 38.12% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$73.33
Price Target Difference	38.12%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	15.26%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1